4K® score test in the time of COVID-19 quarantine - implications for timely diagnosis of high-risk prostate cancer
Friedman Boris1,Neuberger Ami2, Ephrat Omer1, Manaster Yoav3, Freifeld Yuval1, Dekel Yoram1
1- Urology Department, Carmel Lady Davis medical center, Haifa, Israel
2 - Infectious Disease Department, Rambam Health care Campus, Haifa, Israel
3 - Progenetics company LTD
Friedman Boris – friedmanboris173@gmail.com
Neuberger Ami – a_neuberger@rambam.health.gov.il
Ephrat Omer – omerephratmed@gmail.com
Manaster Yoav – yoav@progenetics.co.il
Freifeld Yuval – yuvalfr@clalit.org.il
Dekel Yoram - yoramd@clalit.org.il